Dirk Honemann
Overview
Explore the profile of Dirk Honemann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
473
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Banaszek A, Bumm T, Nowotny B, Geis M, Jacob K, Wolfl M, et al.
Nat Commun
. 2019 Nov;
10(1):5387.
PMID: 31772172
T cell-engaging immunotherapies are changing the landscape of current cancer care. However, suitable target antigens are scarce, restricting these strategies to very few tumor types. Here, we report on a...
2.
Ritchie D, Neeson P, Khot A, Peinert S, Tai T, Tainton K, et al.
Mol Ther
. 2013 Jul;
21(11):2122-9.
PMID: 23831595
In a phase I study of autologous chimeric antigen receptor (CAR) anti-LeY T-cell therapy of acute myeloid leukemia (AML), we examined the safety and postinfusion persistence of adoptively transferred T...
3.
Bajel A, Lin M, Hill P, Goodman D, McCormack C, Foley P, et al.
Leuk Lymphoma
. 2009 Oct;
50(12):2083-5.
PMID: 19863174
No abstract available.
4.
Prince H, Honemann D, Spencer A, Rizzieri D, Stadtmauer E, Roberts A, et al.
Blood
. 2009 May;
113(19):4819-20.
PMID: 19423744
No abstract available.
5.
Westwood J, Murray W, Trivett M, Haynes N, Solomon B, Mileshkin L, et al.
J Immunother
. 2009 Feb;
32(3):292-301.
PMID: 19242371
In this study we aimed to determine the suitability of the Lewis-Y carbohydrate antigen as a target for immunotherapy using genetically redirected T cells. Using the 3S193 monoclonal antibody and...
6.
Prince H, Wall D, Ritchie D, Honemann D, Harrrison S, Quach H, et al.
J Immunother
. 2008 May;
31(2):166-79.
PMID: 18481386
Dendritic cell (DC) immunotherapy is being actively studied in multiple myeloma (MM). We aimed to use positron emission tomography or single positron emission tomography to determine the in vivo distribution...
7.
Mileshkin L, Honemann D, Gambell P, Trivett M, Hayakawa Y, Smyth M, et al.
Haematologica
. 2007 Jul;
92(8):1075-82.
PMID: 17640854
Background And Objectives: In vitro studies suggest that thalidomide has an immunoregulatory role and alters the marrow microenvironment. We assessed laboratory and clinical parameters in patients with myeloma treated with...
8.
9.
Robinson H, Damasiewicz M, Honemann D, Lade S, Boussioutas A, Prince H
Leuk Lymphoma
. 2006 Oct;
47(9):1973-5.
PMID: 17065017
No abstract available.
10.
Kenealy M, Prince H, Honemann D
Pharmacotherapy
. 2006 Jul;
26(8):1205-6.
PMID: 16863501
No abstract available.